Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion type Assertion NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_head.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion description "[A total of 143 genetic polymorphisms in 13 candidate genes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, ALDH1A1, ALDH3A1, GSTA1, GSTM1, GSTP1, GSTT1, ABCC2 and ABCC4), possibly involved in the activation, metabolism and transport of CPA, were genotyped using 184 cases who developed either > or =grade 3 leukopenia/neutropenia or > or =grade 2 gastrointestinal toxicity and 219 controls who did not show any ADRs throughout the treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_provenance.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion evidence source_evidence_literature NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_provenance.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion SIO_000772 19696793 NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_provenance.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion wasDerivedFrom befree-20140225 NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_provenance.
- NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_assertion wasGeneratedBy ECO_0000203 NP611103.RAI6yCEZ-iltVIwvS5jcbvDgWArsbUnFPtPZEWYFUlB5Q130_provenance.